article · BMJ Open Diabetes Research & Care
Type 2 diabetes mellitus (T2DM) is characterised by persistent high blood sugar, which is linked to an overactive hypothalamic-pituitary-adrenal (HPA) axis, the body's stress response system. This hyperactivity is heightened in chronic high blood sugar states, increasing the likelihood of depression. In T2DM, the immune system is dysregulated, leading to elevated pro-inflammatory cytokines. These cytokines further activate the HPA axis, contributing to depression in patients with T2DM. Importantly, complications often seen in T2DM can begin during the pre-diabetic stage, a reversible state of moderate high blood sugar. Further clinical research is needed to investigate the direct effects of moderate high blood sugar in pre-diabetes on the HPA axis, and its indirect effects via the immune system.
This research highlights how high blood sugar in diabetes not only affects physical health but also significantly impacts mental well-being by disrupting the body's stress response and immune system. Understanding these complex connections is crucial for better managing and preventing depression in diabetic patients, potentially even in the pre-diabetic stage.
The abstract indicates a need for further research and clinical studies to profile the effects of moderate high blood sugar on the HPA axis and immune system in pre-diabetes. This work is foundational, aiming to deepen understanding of disease mechanisms. It does not currently suggest direct commercial applications or products, but rather points towards future diagnostic or therapeutic targets.
AI-generated from the published abstract. Always read the original work before citing.
Type 2 diabetes mellitus (T2DM) is characterized by persistent hyperglycemia which is further associated with hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. Several studies have shown that HPA axis hyperactivity is heightened in the chronic hyperglycemic state with severe hyperglycemic events more likely to result in a depressive disorder. The HPA axis is also regulated by the immune system. Upon stress, under homeostatic conditions, the immune system is activated via the sympatho-adrenal-medullary axis resulting in an immune response which secretes proinflammatory cytokines. These cytokines aid in the activation of the HPA axis during stress. However, in T2DM, where there is persistent hyperglycemia, the immune system is dysregulated resulting in the elevated concentrations of these cytokines. The HPA axis, already activated by the hyperglycemia, is further activated by the cytokines which all contribute to a diagnosis of depression in patients with T2DM. However, the onset of T2DM is often preceded by pre-diabetes, a reversible state of moderate hyperglycemia and insulin resistance. Complications often seen in T2DM have been reported to begin in the pre-diabetic state. While the current management strategies have been shown to ameliorate the moderate hyperglycemic state and decrease the risk of developing T2DM, research is necessary for clinical studies to profile these direct effects of moderate hyperglycemia in pre-diabetes on the HPA axis and the indirect effects moderate hyperglycemia may have on the HPA axis by investigating the components of the immune system that play a role in regulating this pathway.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1136/bmjdrc-2022-003218
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
